Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 23;7(10):1281-94.
doi: 10.7150/jca.13141. eCollection 2016.

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

Affiliations
Free PMC article
Review

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

Xiaofeng Dai et al. J Cancer. .
Free PMC article

Abstract

Breast cancer is a complex disease encompassing multiple tumor entities, each characterized by distinct morphology, behavior and clinical implications. Besides estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2, novel biomarkers have shown their prognostic and predictive values, complicating our understanding towards to the heterogeneity of such cancers. Ten cancer hallmarks have been proposed by Weinberg to characterize cancer and its carcinogenesis. By reviewing biomarkers and breast cancer molecular subtypes, we propose that the divergent outcome observed from patients stratified by hormone status are driven by different cancer hallmarks. 'Sustaining proliferative signaling' further differentiates cancers with positive hormone receptors. 'Activating invasion and metastasis' and 'evading immune destruction' drive the differentiation of triple negative breast cancers. 'Resisting cell death', 'genome instability and mutation' and 'deregulating cellular energetics' refine breast cancer classification with their predictive values. 'Evading growth suppressors', 'enabling replicative immortality', 'inducing angiogenesis' and 'tumor-promoting inflammation' have not been involved in breast cancer classification which need more focus in the future biomarker-related research. This review novels in its global view on breast cancer heterogeneity, which clarifies many confusions in this field and contributes to precision medicine.

Keywords: biomarker; breast cancer; cancer hallmarks; subtype..

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Similar articles

See all similar articles

Cited by 50 articles

See all "Cited by" articles

References

    1. Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A. Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2009;20:628–35. - PubMed
    1. Tang P, Wang J, Bourne P. Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same? Human pathology. 2008;39:506–13. - PubMed
    1. Desmedt C, Sotiriou C, Piccart-Gebhart MJ. Development and validation of gene expression profile signatures in early-stage breast cancer. Cancer investigation. 2009;27:1–10. - PubMed
    1. Iwamoto T, Pusztai L. Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data? Genome medicine. 2010;2:81. - PMC - PubMed
    1. Reis-Filho JS, Weigelt B, Fumagalli D, Sotiriou C. Molecular profiling: moving away from tumor philately. Science translational medicine. 2010;2:47ps3. - PubMed
Feedback